Verteporfin Photodynamic Therapy for the Treatment of Retinal Vasoproliferative Tumors

Ophthalmology. 2015 Nov;122(11):2361-3. doi: 10.1016/j.ophtha.2015.05.026. Epub 2015 Jun 23.

Authors

Rumana N Hussain¹, Fidan Jmor², Bertil Damato³, Heinrich Heimann²

Affiliations

¹ Liverpool Ocular Oncology Service, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK. Electronic address: rumanahussain@hotmail.com.
² Liverpool Ocular Oncology Service, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
³ Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, California.

PMID: 26116341
DOI: 10.1016/j.ophtha.2015.05.026

No abstract available

MeSH terms

Adult
Aged
Female
Hemangioma / diagnosis
Hemangioma / drug therapy*
Humans
Male
Middle Aged
Photochemotherapy*
Photosensitizing Agents / therapeutic use*
Porphyrins / therapeutic use*
Retinal Neoplasms / diagnosis
Retinal Neoplasms / drug therapy*
Retinal Vessels / drug effects*
Retinal Vessels / pathology
Subretinal Fluid
Verteporfin
Visual Acuity

Substances

Photosensitizing Agents
Porphyrins
Verteporfin